ProQR Therapeutics (PRQR) EPS (Basic) (2013 - 2025)
ProQR Therapeutics recorded quarterly EPS (Basic) of -$0.07 in Q4 2025, up 100.0% quarter-over-quarter from -$34465.6 in Q3 2025, and up 96.51% year-over-year from -$0.04 in Q4 2024.
ProQR Therapeutics' EPS (Basic) history runs 13 years deep, the most recent figure standing at -$0.07 for Q4 2025.
- In Q4 2025, EPS (Basic) rose 96.51% year-over-year to -$0.07; the TTM figure through Dec 2025 stood at -$200208.6 (down 40.31% YoY), while the FY2025 annual figure was -$0.47, down 36.17% from the prior year.
- EPS (Basic) came in at -$0.07 for Q4 2025 at ProQR Therapeutics, up from -$34465.6 in the prior quarter.
- In the past five years, EPS (Basic) ranged from a high of -$0.06 in Q4 2023 to a low of -$104500.0 in Q1 2025.
- A 5-year average of -$36441.6 and a median of -$33781.8 in 2021 frame the typical range for EPS (Basic).
- Across the five-year window, EPS (Basic) slumped 15675150.28% in 2021 and soared 96.51% in 2025, its largest moves.
- ProQR Therapeutics' EPS (Basic) stood at -$0.24 in 2021, then soared by 35.15% to -$0.16 in 2022, then soared by 61.4% to -$0.06 in 2023, then slumped by 3406.49% to -$2.14 in 2024, then jumped by 96.51% to -$0.07 in 2025.
- According to Business Quant data, EPS (Basic) over the past three periods registered -$0.07, -$34465.6, and -$61242.9 for Q4 2025, Q3 2025, and Q2 2025 respectively.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EPS (Basic) (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - | 3.06 |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - | - |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn | 0.00 |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - | 0.00 |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn | 4.06 |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - | 0.00 |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn | 6.99 |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn | 1.55 |
| 10 | ProQR Therapeutics | 174.11 Mn | 66.54 Mn | - | -0.07 |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | -0.07 |
| Sep 30, 2025 | -34,465.63 |
| Jun 30, 2025 | -61,242.86 |
| Mar 31, 2025 | -104,500.00 |
| Dec 31, 2024 | -2.14 |
| Sep 30, 2024 | -36,891.30 |
| Jun 30, 2024 | -20,707.69 |
| Mar 31, 2024 | -85,088.89 |
| Dec 31, 2023 | -0.06 |
| Sep 30, 2023 | -21,589.29 |
| Jun 30, 2023 | -38,061.90 |
| Mar 31, 2023 | -83,200.00 |
| Dec 31, 2022 | -0.16 |
| Sep 30, 2022 | -32,386.11 |
| Jun 30, 2022 | -35,128.21 |
| Mar 31, 2022 | -70,545.00 |
| Dec 31, 2021 | -0.24 |
| Sep 30, 2021 | -21,495.71 |
| Jun 30, 2021 | -33,097.92 |
| Mar 31, 2021 | -50,428.00 |
| Dec 31, 2020 | -0.25 |
| Sep 30, 2020 | -20,053.73 |
| Jun 30, 2020 | -10,617.50 |
| Mar 31, 2020 | -0.32 |
| Dec 31, 2019 | -0.34 |
| Sep 30, 2019 | -12,386.73 |
| Jun 30, 2019 | -17,653.03 |
| Mar 31, 2019 | -39,325.00 |
| Dec 31, 2018 | -0.38 |
| Sep 30, 2018 | -8,052.70 |
| Jun 30, 2018 | -12,880.70 |
| Mar 31, 2018 | 0.32 |
| Dec 31, 2017 | 0.44 |
| Sep 30, 2017 | 0.08 |
| Jun 30, 2017 | -12,351.09 |
| Mar 31, 2017 | 23,288.89 |
| Dec 31, 2016 | -0.38 |
| Sep 30, 2016 | -0.43 |
| Jun 30, 2016 | -0.43 |
| Mar 31, 2016 | -0.38 |
| Dec 31, 2015 | -0.26 |
| Sep 30, 2015 | -0.27 |
| Jun 30, 2015 | -0.37 |
| Mar 31, 2015 | -11.67 Mn |
| Dec 31, 2014 | -0.09 |
| Sep 30, 2014 | -0.43 |
| Mar 31, 2014 | -0.29 |
| Dec 31, 2013 | -2,769.49 |
| Sep 30, 2013 | -2,920.00 |